Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge

Area of Science:

• Immunology
• Pulmonology
• Microbiology

Background:

• Elevated immunoglobulin E (IgE) is common in late-onset asthma, often polyclonal with low specific IgE.
• Specific IgE to Staphylococcal enterotoxins (se-IgE) is frequently found in severe late-onset asthma patients.
• se-IgE has shown potential in predicting the development of severe asthma with exacerbations.

Purpose of the Study:

• To review the current understanding of Staphylococcus aureus's role in severe asthma.
• To highlight the impact of S. aureus proteins on airway inflammation and disease severity.
• To identify research gaps regarding S. aureus and asthma.

Main Methods:

• Review of existing literature on S. aureus, IgE, and asthma.
• Analysis of mechanisms by which S. aureus proteins affect airway mucosal immunology.
• Discussion of clinical associations between se-IgE and asthma severity.

Main Results:

• S. aureus proteins manipulate airway immunity, including IL-33 release, ILC and Th2 activation, mast cell degranulation, and IgE formation.
• These mechanisms contribute to airway inflammation, epithelial damage, and disease persistence.
• S. aureus is implicated in orchestrating severe airway inflammation and influencing current and future asthma severity.

Conclusions:

• Staphylococcus aureus plays a significant role in the pathogenesis of severe asthma.
• Understanding S. aureus's impact is crucial for managing severe asthma and predicting its progression.
• Further research is needed to fully elucidate the mechanisms involved and develop targeted therapies.